
Need information?
CONTACT US
ARGENE® Respiratory range
Real-time PCR detection kits for viral respiratory diseases
- Complete and ready-to-use kits
- Validated on major extraction and amplification platforms
Do you need more information?
ARGENE® Respiratory advantages
- Modular multiplex solution
- Targeted diagnostic strategy with an “à la carte” menu
- Choose which pathogens to test depending on the season
- Allow the diagnosis of co-infections
- Sensitive and reproducible
- Reliable detection of infectious agents involved in viral respiratory diseases
- All controls included (positive control, negative control, internal control)
- Internal control is an endogenous internal control to check for extraction/amplification process and sample quality
- Flexible
- Validated for use with various upper and lower respiratory samples
- For use on manual workflow or on automated ARGENE® SOLUTION workflow
- Validated for use on major extraction and amplification platforms
Everything you need in one kit
R-GENE® kits include all necessary reagents:
• Ready-to-use amplification premix (including Taq polymerase)
• Reverse transcriptase
• Positive control
• Negative control
Easy procedure
Using R-GENE® assay is easy.
SARS-COV-2/FLUA/FLUB/RSV R-GENE® | COVID-19R-GENE® | RHINO&EV/CcR-GENE® | |
---|---|---|---|
Ordering information | Reference: 424433 Designation: SARS-COV-2/FLUA/FLUB/RSV R-GENE® |
Reference: 424017 Designation: COVID-19 R-GENE® |
Reference: 71-042 Designation: Rhino&EV/Cc R-GENE® |
Test principle | Real Time PCR Detection kit | ||
Technology | Real-Time PCR / 5’ nuclease technology | ||
PCR design | 5-PLEX PCR 1. SARS-CoV-2 2. Influenza A 3. Influenza B 4. RSV 5. Endogenous Internal Control |
2-PLEX PCR 1. SARS-CoV-2 2. Endogenous Internal Control |
2-PLEX PCR 1. Rhino&EV 2. Endogenous Internal Control |
Targeted genes |
SARS-CoV-2: N & RdRp genes |
SARS-CoV-2: N & RdRp genes |
Rhinovirus A/B/C: non coding 5' region |
Specimens | Nasopharyngeal Swab | Nasopharyngeal Swab Saliva |
Nasopharyngeal Swab Nasopharyngeal Aspirate Bronchoalveolar Lavage |
Extraction platforms | • EMAG® • NUCLISENS® easyMAG® • QIAsymphony SP • MagNA Pure 96 • MGISP 960 |
• EMAG® • NUCLISENS® easyMAG® • QIAsymphony SP • MagNA Pure 96 • MGISP 960 |
• EMAG® • NUCLISENS® easyMAG® • QIAsymphony SP |
Amplification platforms | • QuantStudio 5 • QuantStudio 5 Dx • CFX96 • CFX Opus 96 |
• QuantStudio 5 • QuantStudio 5 Dx • CFX96 • CFX Opus 96 • 7500 Fast • 7500 Fast Dx • LightCycler 480 (System II) |
• QuantStudio 5 • QuantStudio 5 Dx • CFX96 • CFX Opus 96 • 7500 Fast • 7500 Fast Dx • LightCycler 480 (System II) |
Kit content | All included (amplification premix, reverse transcriptase, positive control, negative control) | ||
Controls included | Positive Control, Negative Control, Endogenous Internal Control | ||
Number of tests | 96 tests | 96 tests | 60 tests |
Storage conditions | -15°C / -31°C | ||
Status | For In Vitro Diagnostic use (CE marked under EU regulation 2017/746) | For In Vitro Diagnostic use (CE marked under EU directive 98/79/CE) | For In Vitro Diagnostic use (CE marked under EU regulation 2017/746) |
Fast facts on Respiratory Pathogens
What are Respiratory Pathogens?
The vast majority of respiratory illnesses are caused by viruses and bacteria. In both children and adults, acute respiratory infections (ARI) are most frequently due to infections with Influenza A and B viruses, Parainfluenza viruses 1, 2 and 3, Respiratory Syncytial Virus (RSV A and B), Adenoviruses and Rhinoviruses. Others pathogens such as Coronaviruses, Bocaviruses, Enteroviruses, Parainfluenza 4, human Metapneumovirus, Mycoplasma pneumonia, Chlamydia pneumoniae, Legionella pneumophila, Bordetella pertussis and Bordetella parapertussis also infect the respiratory tract and can cause various diseases from mild self-limiting upper respiratory infections to potentially threatening pneumonia.
Who is most at risk?
Anyone can become infected and ill with these respiratory pathogens. However, young children, the elderly, immunocompromised or weakened individuals (including those with chronic disease, cancer, or in intensive care) are most likely to suffer serious and potentially life-threatening pneumopathies.
What are the benefits of Respiratory pathogens molecular testing?
Clinical symptoms for different respiratory illnesses are similar so in vitro diagnostic molecular methods are necessary to determine the causative agents. Early, rapid and specific detection of the virus or bacteria involved using real-time PCR methods is essential to provide patient-tailored therapy for better outcomes. An accurate diagnosis will also help to control outbreaks, reduce potential antibiotic resistance and facilitate a more rapid patient recovery.
ARGENE® Respiratory: PUBLICATIONS & POSTERS
Infections respiratoires aigües : étude comparative des trousses d’amplification génique en temps réel respiratory multi well system r-gene de BioMérieux et Respiratory pathogens 21 de Fast Track diagnostics.
Trombert-Paolantoni S., Hedbaut E., Clairet V
RICAI 2015
Pattern of Respiratory Pathogen Nasal Colonization in the first year of life in Healthy Infants and Infants with Cystic Fibrosis
Insa Korten et al.
Poster ESCV 2016
BioMérieux molecular workflow : solution for ARGENE® product range automation
Bourdin Jérôme; Levillain Erwan; Bes Jérôme; Guy Michel; Margry Pascal; Bufflier Emmanuel; Chini Giorgio; Pradier Nicolas; Magro Stephane; Brengel-Pesce Karen
Poster ESCV 2014
Please consult your local bioMérieux representative for product availability in your country
COMPLETE YOUR SOLUTION
- Legal Notice
- Privacy
- Cookie Policy
- Contact
- Sitemap
- Copyright 2023 bioMérieux SA